OptiNose Inc (OPTN)
1.01
+0.13
(+15.09%)
USD |
NASDAQ |
May 03, 16:00
1.003
-0.01
(-0.72%)
After-Hours: 20:00
OptiNose Cash from Operations (TTM): -20.53M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -20.53M |
| September 30, 2023 | -45.12M |
| June 30, 2023 | -58.19M |
| March 31, 2023 | -58.79M |
| December 31, 2022 | -67.65M |
| September 30, 2022 | -66.69M |
| June 30, 2022 | -58.89M |
| March 31, 2022 | -68.25M |
| December 31, 2021 | -76.94M |
| September 30, 2021 | -79.38M |
| June 30, 2021 | -85.21M |
| March 31, 2021 | -86.26M |
| December 31, 2020 | -86.21M |
| Date | Value |
|---|---|
| September 30, 2020 | -85.16M |
| June 30, 2020 | -84.75M |
| March 31, 2020 | -89.09M |
| December 31, 2019 | -90.82M |
| September 30, 2019 | -92.90M |
| June 30, 2019 | -101.91M |
| March 31, 2019 | -98.51M |
| December 31, 2018 | -91.82M |
| September 30, 2018 | -85.42M |
| June 30, 2018 | -69.54M |
| March 31, 2018 | -51.15M |
| December 31, 2017 | -35.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-101.91M
Minimum
Jun 2019
-20.53M
Maximum
Dec 2023
-73.83M
Average
-79.38M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Zevra Therapeutics Inc | -33.54M |
| Madrigal Pharmaceuticals Inc | -324.23M |
| Viking Therapeutics Inc | -54.87M |
| Spero Therapeutics Inc | -33.00M |
| Karuna Therapeutics Inc (DELISTED) | -385.82M |